Atara Biotherapeutics (ATRA) Enterprise Value Growth (5y) (2018 - 2026)
Atara Biotherapeutics (ATRA) Enterprise Value Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.64% |
| Dec 31, 2025 | 46.88% |
| Sep 30, 2025 | 38.03% |
| Jun 30, 2025 | 21.46% |
| Mar 31, 2025 | 42.20% |
| Dec 31, 2024 | 19.51% |
| Sep 30, 2024 | 30.28% |
| Jun 30, 2024 | 28.60% |
| Mar 31, 2024 | 3.88% |
| Dec 31, 2023 | 3.21% |
| Sep 30, 2023 | 26.36% |
| Jun 30, 2023 | 31.94% |
| Mar 31, 2023 | 31.25% |
| Dec 31, 2022 | -25.05% |
| Sep 30, 2022 | 19.79% |
| Jun 30, 2022 | 13.97% |
| Mar 31, 2022 | -12.38% |
| Dec 31, 2021 | 16.10% |
| Sep 30, 2021 | -5.13% |
| Jun 30, 2021 | 15.88% |